 | • レポートコード：QFJ1-4516 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、胆嚢がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胆嚢がん分子診断の市場動向 ・企業の競争状況、市場シェア ・胆嚢がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・胆嚢がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・胆嚢がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・胆嚢がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆嚢がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆嚢がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆嚢がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Premed、Inmedi、United Gene Group、1GENE） ・結論 |
A method for diagnosing gallbladder cancer
Market Analysis and Insights: Global Molecular Diagnosis of Gallbladder Cancer Market
The global Molecular Diagnosis of Gallbladder Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis of Gallbladder Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis of Gallbladder Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis of Gallbladder Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis of Gallbladder Cancer market.
Global Molecular Diagnosis of Gallbladder Cancer Scope and Market Size
Molecular Diagnosis of Gallbladder Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis of Gallbladder Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Premed
Inmedi
United Gene Group
1GENE
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Gallbladder Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Gallbladder Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis of Gallbladder Cancer Market Perspective (2016-2027)
2.2 Molecular Diagnosis of Gallbladder Cancer Growth Trends by Regions
2.2.1 Molecular Diagnosis of Gallbladder Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis of Gallbladder Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis of Gallbladder Cancer Industry Dynamic
2.3.1 Molecular Diagnosis of Gallbladder Cancer Market Trends
2.3.2 Molecular Diagnosis of Gallbladder Cancer Market Drivers
2.3.3 Molecular Diagnosis of Gallbladder Cancer Market Challenges
2.3.4 Molecular Diagnosis of Gallbladder Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Gallbladder Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Gallbladder Cancer Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis of Gallbladder Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Gallbladder Cancer Revenue
3.4 Global Molecular Diagnosis of Gallbladder Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Gallbladder Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Gallbladder Cancer Revenue in 2020
3.5 Molecular Diagnosis of Gallbladder Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Gallbladder Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Gallbladder Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis of Gallbladder Cancer Breakdown Data by Type
4.1 Global Molecular Diagnosis of Gallbladder Cancer Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnosis of Gallbladder Cancer Breakdown Data by Application
5.1 Global Molecular Diagnosis of Gallbladder Cancer Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnosis of Gallbladder Cancer Market Size (2016-2027)
6.2 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type
6.2.1 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application
6.3.1 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Country
6.4.1 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Gallbladder Cancer Market Size (2016-2027)
7.2 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type
7.2.1 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application
7.3.1 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Country
7.4.1 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type
9.2.1 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application
9.3.1 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Country
9.4.1 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Molecular Diagnosis of Gallbladder Cancer Introduction
11.1.4 Premed Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
11.1.5 Premed Recent Development
11.2 Inmedi
11.2.1 Inmedi Company Details
11.2.2 Inmedi Business Overview
11.2.3 Inmedi Molecular Diagnosis of Gallbladder Cancer Introduction
11.2.4 Inmedi Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
11.2.5 Inmedi Recent Development
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Molecular Diagnosis of Gallbladder Cancer Introduction
11.3.4 United Gene Group Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
11.3.5 United Gene Group Recent Development
11.4 1GENE
11.4.1 1GENE Company Details
11.4.2 1GENE Business Overview
11.4.3 1GENE Molecular Diagnosis of Gallbladder Cancer Introduction
11.4.4 1GENE Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
11.4.5 1GENE Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnosis of Gallbladder Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Gallbladder Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnosis of Gallbladder Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Diagnosis of Gallbladder Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Regions (2016-2021)
Table 10. Global Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Regions (2022-2027)
Table 12. Molecular Diagnosis of Gallbladder Cancer Market Trends
Table 13. Molecular Diagnosis of Gallbladder Cancer Market Drivers
Table 14. Molecular Diagnosis of Gallbladder Cancer Market Challenges
Table 15. Molecular Diagnosis of Gallbladder Cancer Market Restraints
Table 16. Global Molecular Diagnosis of Gallbladder Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Players (2016-2021)
Table 18. Global Top Molecular Diagnosis of Gallbladder Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Gallbladder Cancer as of 2020)
Table 19. Ranking of Global Top Molecular Diagnosis of Gallbladder Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Gallbladder Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnosis of Gallbladder Cancer Product Solution and Service
Table 23. Date of Enter into Molecular Diagnosis of Gallbladder Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Diagnosis of Gallbladder Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Diagnosis of Gallbladder Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Premed Company Details
Table 64. Premed Business Overview
Table 65. Premed Molecular Diagnosis of Gallbladder Cancer Product
Table 66. Premed Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021) & (US$ Million)
Table 67. Premed Recent Development
Table 68. Inmedi Company Details
Table 69. Inmedi Business Overview
Table 70. Inmedi Molecular Diagnosis of Gallbladder Cancer Product
Table 71. Inmedi Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021) & (US$ Million)
Table 72. Inmedi Recent Development
Table 73. United Gene Group Company Details
Table 74. United Gene Group Business Overview
Table 75. United Gene Group Molecular Diagnosis of Gallbladder Cancer Product
Table 76. United Gene Group Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021) & (US$ Million)
Table 77. United Gene Group Recent Development
Table 78. 1GENE Company Details
Table 79. 1GENE Business Overview
Table 80. 1GENE Molecular Diagnosis of Gallbladder Cancer Product
Table 81. 1GENE Revenue in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021) & (US$ Million)
Table 82. 1GENE Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Molecular Diagnosis of Gallbladder Cancer Report Years Considered
Figure 11. Global Molecular Diagnosis of Gallbladder Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Diagnosis of Gallbladder Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Regions (2022-2027)
Figure 15. Global Molecular Diagnosis of Gallbladder Cancer Market Share by Players in 2020
Figure 16. Global Top Molecular Diagnosis of Gallbladder Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Gallbladder Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Gallbladder Cancer Revenue in 2020
Figure 18. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Diagnosis of Gallbladder Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Diagnosis of Gallbladder Cancer Market Share by Type (2016-2027)
Figure 22. North America Molecular Diagnosis of Gallbladder Cancer Market Share by Application (2016-2027)
Figure 23. North America Molecular Diagnosis of Gallbladder Cancer Market Share by Country (2016-2027)
Figure 24. United States Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Diagnosis of Gallbladder Cancer Market Share by Type (2016-2027)
Figure 28. Europe Molecular Diagnosis of Gallbladder Cancer Market Share by Application (2016-2027)
Figure 29. Europe Molecular Diagnosis of Gallbladder Cancer Market Share by Country (2016-2027)
Figure 30. Germany Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Diagnosis of Gallbladder Cancer Market Share by Region (2016-2027)
Figure 40. China Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Diagnosis of Gallbladder Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Diagnosis of Gallbladder Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Diagnosis of Gallbladder Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Diagnosis of Gallbladder Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Diagnosis of Gallbladder Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Premed Revenue Growth Rate in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
Figure 60. Inmedi Revenue Growth Rate in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
Figure 61. United Gene Group Revenue Growth Rate in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
Figure 62. 1GENE Revenue Growth Rate in Molecular Diagnosis of Gallbladder Cancer Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…- 世界の直腸がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing rectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Rectal Cancer Market The global Molecular Diagnosis of Rectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.…
- 世界の結核分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing tuberculosis Market Analysis and Insights: Global Molecular Diagnosis of Tuberculosis Market The global Molecular Diagnosis of Tuberculosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. Wi…
- 世界の鼻咽頭癌分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing nasopharyngeal carcinoma Market Analysis and Insights: Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market The global Molecular Diagnosis of Nasopharyngeal Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の手足口病分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing Hand, Foot and Mouth Disease Market Analysis and Insights: Global Molecular Diagnosis of Hand, Foot and Mouth Disease Market The global Molecular Diagnosis of Hand, Foot and Mouth Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…